Onco-Metabolic Surgery: A Combined Approach to Gastric Cancer and Hypertension
Onco-Metabolic Surgery: A Combined Approach to Gastric Cancer and Hypertension
Blog Article
Dong Peng,* Yu-Xi Cheng,* Wei Tao, Ying-Ying Zou, Kun Qian, Wei Zhang Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wei Zhang; Kun QianDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, People’s Republic of ChinaEmail [email protected]; [email protected]: The purpose of this study was to explore the changes in blood pressure in patients with concurrent gastric cancer and Figure Skating - Boots - Mens hypertension after gastrectomy, and to identify the factors that affect the changes in blood pressure.
Materials and Methods: Patients with concurrent gastric cancer and hypertension who underwent gastrectomy were retrospectively analyzed from January 2013 to December 2018.The pre- and 6-month postoperative medical records were compared.Predictors for the remission of hypertension were analyzed.
Results: A total of 143 patients with concurrent gastric cancer and hypertension were included in this study.The number of patients with complete remission, partial remission and no remission were 67 (46.9%), 12 (8.
4%) and 64 (44.7%), respectively.The average of weight and BMI (body mass index) before gastrectomy were 63.
0 ± 9.7 kg and 23.4 ± 2.
9 kg/m2, respectively, which were significantly higher than those 6-month postgastrectomy: 54.8 ± 9.8 kg and 20.
4 ± 3.1 kg/m2, respectively (p< 0.001).
The average number of antihypertensive medications before gastrectomy was 1.5 ± 0.6, while it was 0.
8 ± 0.8 6-month postgastrectomy (p< 0.001).
Age (p< 0.05) and the surgical techniques used (p< 0.05) were significantly different between partial remission and no remission patients.
Furthermore, age (p< 0.05) and the Warranty surgical techniques used (p< 0.05) were significantly different between complete remission and no remission patients.
Age (p< 0.05, odds ratio =0.933, 95% CI=0.
890– 0.978) and the surgical techniques used (p< 0.05, odds ratio =2.
749, 95% CI=1.132– 6.677) are predictors for remission of hypertension.
Conclusion: Total gastrectomy is an onco-metabolic surgery that can cure younger patients with concurrent gastric cancer and hypertension.Age and the surgical techniques used can predict the remission of hypertension 6 months after gastrectomy.Keywords: gastric cancer, age, hypertension, gastrectomy, remission.